Finally, we reveal that Barx2 inhibits Wnt/β-catenin signaling pathway by decreasing expression of its downstream target genes in GC, highlighting its importance in altered cell signaling leading to GC carcinogenesis and progression. Here, BARX2 is linked to gastric cancer.